BONARDI, MARIA SANTINA
BONARDI, MARIA SANTINA
Collaboratori
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases
2008-01-01 Generali, Daniele; Dovio, A.; Tampellini, M.; Tucci, M.; Tedoldi, S.; Torta, M.; Bonardi, MARIA SANTINA; Allevi, G.; Aguggini, S.; Milani, M.; Harris, A. L.; Bottini, A.; Dogliotti, L.; Angeli, A.; Berruti, A.
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?[5]
2006-01-01 Ardine, M.; Generali, Daniele; Donadio, M.; Bonardi, MARIA SANTINA; Scoletta, M.; Vandone, A. M.; Mozzati, M.; Bertetto, O.; Bottini, A.; Dogliotti, L.; Berruti, Alfredo
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
2016-01-01 Andreis, D.; Bonardi, S.; Allevi, G.; Aguggini, S.; Gussago, F.; Milani, M.; Strina, C.; Spada, D.; Ferrero, G.; Ungari, M.; Rocca, Andrea.; Nanni, O.; Roviello, G.; Berruti, A.; Harris, A. L.; Fox, S. B.; Roviello, F.; Polom, K.; Bottini, A.; Generali, D.